Real-World Use of Ide-cel Provides Favorable Outcomes in CNS Myeloma 

Patients treated with ide-cel, Abecma for relapsed/refractory multiple myeloma affecting the central nervous system had similar outcomes to matched patients with non-CNS multiple myeloma.